The 22nd Awaji International Forum on Infection and Immunity

○Lucy Muthoni Mwai¹, Bernard Kanoi¹, Jesse Gitaka¹, Hikaru Nagaoka², Sebastian Musundi¹, Takafumi Tsuboi², Eizo Takashima² (1. Mount Kenya University (Kenya), 2. Proteo-Science Center, Ehime University (Japan))

○MATTHEW MUTINDA MUNYAO¹, Tonny Teya Nyandwaro¹, Doris Wairimu Njomo¹, Eberhard Eugen Zeyhle², Nicole Siena Tanchu⁴, Anne Wanjiru Mwangi¹, Caroline Wangui Njoroge¹, Robinson Irekwa Mugasiali¹, Peter Kipkemboi Rotich¹, Joanne Jepkemei Yego¹, Grace Ngendo Kanyita³, Vincent Kiplangat Ruttoh⁵, Samson Muuo Nzou¹ (1. KENYA MEDICAL RESEARCH INSTITUTE (Kenya), 2. Meru University Science and Technology (Kenya), 3. Department of Biochemistry, Microbiology & Biotechnology, Kenyatta University (Kenya), 4. KEMRI Graduate School (Kenya), 5. Center for Virus Research (Kenya))

○ABHISHEK CHATTERJEE¹, Dr. ABUL HASAN SARDAR¹ (1. SARSUNA COLLEGE, University of Calcutta (India))

○Abraham Anane¹, Ebenezer Nartey⁴, Francis Addy², Osman Dufailu³ (1. Department of Virology, Noguchi Memorial Institute for Medical Research (Ghana), 2. Department of Biotechnology, Faculty of Biosciences, University for Development Studies, Tamale (Ghana), 3. Department of Microbiology, Faculty of Biosciences, University for Development Studies, Tamale (Ghana), 4. Department of Ecological Agriculture, School of Agriculture, Bolgatanga Technical University, Bolgatanga (Ghana))

Sachee Bhanu Piyasiri¹, Sanath Senanayake¹, Nilakshi Samaranayake¹, Serena Doh², Eva Iniguez², Shaden Kamhawi², ○Nadira Karunaweera¹ (1. Faculty of Medicine, University of Colombo (Sri Lanka), 2. National Institute of Allergy and Infectious Diseases, National Institute of Health (United States of America))

○Taeko Kagiya Naruse¹, Peterson Mathenge¹, Minami Baba¹, Akira Kaneko², Jesse Gitaka³, Osamu Kaneko¹ (1. Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 2. Department of Parasitology, Graduate School of Medicine, Osaka Metropolitan University (Japan), 3. Mount Kenya University (Kenya))

○Shara Bakytbek^1,2,3, Shin-Ichi Inoue⁴, Farzaneh Valanezhad^1,2,3, Ranadhir Dey⁵, Jalal Alshaweesh⁶, Risa Nakamura^1,2,3, Swarnendu Kaviraj⁷, Shaden Kamhawi⁸, Jesus G. Valenzuela⁸, Sanjay Singh⁷, Abhay R. Satoskar⁹, Sreenivas Gannavaram¹⁰, Hira L. Nakhasi¹⁰, Greg Matlashewski¹¹, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Division of Immunology, Nagasaki University, Nagasaki City, Nagasaki (Japan), 5. Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD (United States of America), 6. Division of Malaria Immunology, Department of Microbiology and Immunology, Institute of Medical Science (IMSUT), Tokyo University (Japan), 7. Gennova Biopharmaceuticals, Hinjawadi Phase II, Pune, Maharashtra (India), 8. Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, 20852 (United States of America), 9. Department of Pathology and Microbiology, Ohio State University, Columbus, OH (United States of America), 10. Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD (United States of America), 11. Department of Microbiology and Immunology, McGill University, Montreal, QC (Canada))

○Farzaneh Valanezhad^1,2,3, Jalal Alshaweesh⁴, Shara Bakytbek^1,2,3, Sakiko Shimizu⁵, Ryo Tanaka⁵, Yoichiro Iwase⁵, Risa Nakamura^1,2,3, Greg Matlashewski⁶, Sreenivas Gannavaram⁷, Hira Nakhasi⁷, Abhay Satoskar⁸, Shinjiro Hamano^1,2,3 (1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo (Japan), 5. TERUMO Corporation, Medical Care Solutions Company, Pharmaceutical Solutions Division, R&D (Japan), 6. Department of Microbiology and Immunology, McGill University, Montreal, QC, (Canada), 7. Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, 20993 US (United States of America), 8. Department of Pathology, The Ohio State University, Columbus, Ohio, (United States of America))

○Joanne Jepkemei Yego¹, Caroline Wangui Njoroge¹, Robinson Mugasiali Irekwa¹, Tonny Teya Nyandwaro¹, Mathew Mutinda Munyao¹, Anne Wanjiru Mwangi¹, Peter Kipkemboi Rotich¹, Daniel Mwiti², Eberhard Eugene Zeyhle³, Samson Muuo Nzou¹ (1. Kenya Medical Research Institute (Kenya), 2. Ministry of Health, Kenya (Kenya), 3. Meru University of Science and Technology (Kenya))